US FDA clearances: Exilis Ultra 360™ is intended for use in non-invasive dermatologic and general surgical procedures for non-invasive treatment of wrinkles and rhytids, to provide a temporary reduction in the appearance of cellulite, and to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain and increase in local circulation. BTL Vanquish ME™ is indicated for temporary reduction in the circumference of the abdomen and thighs. BTL Cellutone™ is cleared for a temporary reduction in the appearance of cellulite. Outside the U.S, BTL aesthetic procedures for non-invasive body shaping, tightening, wrinkle reduction and women’s intimate procedures are available worldwide.
These products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or pending applications.